The Motley Fool

Key Data Points

Primary metrics and data points about ArQule, Inc..
Current Price: $1.70
Prev Close: $1.76
Open: $1.75
Bid: $1.60
Ask: $2.15
Day's Range: $1.68 - $1.79
52wk Range: $1.04 - $2.50
Volume: 161,638
Avg Vol 147,515
Market Cap: $107M
P/E (ttm): -6.07
EPS (ttm): ($0.29)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about ArQule, Inc. from

Business Summary

Industry, sector and description for ArQule, Inc..

A clinical-stage biotechnology company, engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialize targeted cancer drugs with reduced toxicities compared to conventional cancer chemotherapeutics.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

ARQL vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about ArQule, Inc..
CAPS Rating 4 out of 5
175 Outperform
20 Underperform
CAPS All Stars
47 Outperform
6 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paolo Pucci, CEO

26% Approve

Based on 3 Ratings

More Details for ArQuleJobs

Powered by

More Details about ArQule, Inc.

Primary metrics and data points about ArQule, Inc..